These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 35490739)
1. SARS-CoV-2 Omicron sublineage BA.2 replaces BA.1.1: Genomic surveillance in Japan from September 2021 to March 2022. Hirotsu Y; Maejima M; Shibusawa M; Natori Y; Nagakubo Y; Hosaka K; Sueki H; Mochizuki H; Tsutsui T; Kakizaki Y; Miyashita Y; Omata M J Infect; 2022 Aug; 85(2):174-211. PubMed ID: 35490739 [No Abstract] [Full Text] [Related]
2. Analytical sensitivity of the Rapid Antigen Test kits for detection of SARS-CoV-2 Omicron variant BA.2 sublineage. Mak GCK; Lau SSY; Wong KKY; Lau CS; Ng KHL; Lam ETK; Chan RCW J Med Virol; 2022 Oct; 94(10):5033-5037. PubMed ID: 35656593 [TBL] [Abstract][Full Text] [Related]
3. Genomic analysis of SARS-CoV-2 omicron sublineage BA.5.2.1 in Erbil/Iraq. Majed SO; Jalal PJ; Fatah MH; Karim KK; Karim AY; Miasko M; Hasannajad S; Mustafa SA Cell Mol Biol (Noisy-le-grand); 2023 Nov; 69(11):56-63. PubMed ID: 38015540 [TBL] [Abstract][Full Text] [Related]
4. Monitoring of the SARS-CoV-2 Omicron BA.1/BA.2 lineage transition in the Swedish population reveals increased viral RNA levels in BA.2 cases. Lentini A; Pereira A; Winqvist O; Reinius B Med; 2022 Sep; 3(9):636-643.e4. PubMed ID: 35981541 [TBL] [Abstract][Full Text] [Related]
5. Rapid Spread of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Omicron Subvariant BA.2 in a Single-Source Community Outbreak. Cheng VCC; Ip JD; Chu AWH; Tam AR; Chan WM; Abdullah SMU; Chan BPC; Wong SC; Kwan MYW; Chua GT; Ip P; Chan JMC; Lam BHS; To WK; Chuang VWM; Yuen KY; Hung IFN; To KKW Clin Infect Dis; 2022 Aug; 75(1):e44-e49. PubMed ID: 35271728 [TBL] [Abstract][Full Text] [Related]
6. Analyzing and Modeling the Spread of SARS-CoV-2 Omicron Lineages BA.1 and BA.2, France, September 2021-February 2022. Sofonea MT; Roquebert B; Foulongne V; Morquin D; Verdurme L; Trombert-Paolantoni S; Roussel M; Bonetti JC; Zerah J; Haim-Boukobza S; Alizon S Emerg Infect Dis; 2022 Jul; 28(7):1355-1365. PubMed ID: 35642476 [TBL] [Abstract][Full Text] [Related]
7. Development and Validation of an In-House Real-Time Reverse-Transcriptase Polymerase Chain Reaction Assay for SARS-CoV-2 Omicron Lineage Subtyping between BA.1 and BA.2. Pham D; Maddocks S; Dwyer DE; Sintchenko V; Kok J; Rockett RJ Viruses; 2022 Aug; 14(8):. PubMed ID: 36016382 [TBL] [Abstract][Full Text] [Related]
8. A fourth dose of Omicron RBD vaccine enhances broad neutralization against SARS-CoV-2 variants including BA.1 and BA.2 in vaccinated mice. Zhou B; Song S; Guo H; Zhou X; Fan Q; Liu W; Cheng L; Ge X; Ju B; Zhang Z J Med Virol; 2022 Aug; 94(8):3992-3997. PubMed ID: 35474319 [TBL] [Abstract][Full Text] [Related]
9. Editorial: World Health Organization (WHO) Variants of Concern Lineages Under Monitoring (VOC-LUM) in Response to the Global Spread of Lineages and Sublineages of Omicron, or B.1.1.529, SARS-CoV-2. Parums DV Med Sci Monit; 2022 Jul; 28():e937676. PubMed ID: 35775166 [TBL] [Abstract][Full Text] [Related]
10. Occurrence of the Omicron variant of SARS-CoV-2 in northern Viet Nam in early 2022. Ung TTH; Hoang PVM; Nguyen SV; Nguyen HLK; Nguyen PTK; Phan DT; Le TT; Nguyen AP; ; Hasebe F; Le MTQ Western Pac Surveill Response J; 2022; 13(3):1-5. PubMed ID: 36688184 [TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 Omicron BA.1, BA.2, and XAG identification during routine surveillance on a university campus in Belo Horizonte, Brazil, 2022. Queiroz DC; Carobin NV; de Araújo E Santos LCG; Fonseca PLC; Braga-Paz IL; Dias RC; Ferreira JGG; Freitas TR; Menezes D; Nolasco SCVM; Ribeiro SR; Ribeiro TS; do Amaral Xavier L; Gomes KB; de Paula Sabino A; de Aguiar RS; de Souza RP Braz J Microbiol; 2022 Dec; 53(4):2009-2014. PubMed ID: 36272063 [TBL] [Abstract][Full Text] [Related]
12. Genomic characteristics and viral load dynamics of a SARS-CoV-2 Omicron BA.2.2 variant from a hospitalized patient treated with molnupiravir. Chan WS; Law JHY; Ho MKS; Chan TL; Ma ESK; Tang BSF Infect Genet Evol; 2022 Nov; 105():105376. PubMed ID: 36220486 [TBL] [Abstract][Full Text] [Related]
13. Introduction and Rapid Spread of SARS-CoV-2 Omicron Variant and Dynamics of BA.1 and BA.1.1 Sublineages, Finland, December 2021. Vauhkonen H; Nguyen PT; Kant R; Plyusnin I; Erdin M; Kurkela S; Liimatainen H; Ikonen N; Blomqvist S; Liitsola K; Lindh E; Helve O; Jarva H; Loginov R; Palva A; Hannunen T; Hannula S; Parry M; Kauppi P; Vaheri A; Sironen T; Lappalainen M; Savolainen-Kopra C; Smura T; Vapalahti O Emerg Infect Dis; 2022 Jun; 28(6):1229-1232. PubMed ID: 35378057 [TBL] [Abstract][Full Text] [Related]
14. Genomic Surveillance for SARS-CoV-2 Variants: Predominance of the Delta (B.1.617.2) and Omicron (B.1.1.529) Variants - United States, June 2021-January 2022. Lambrou AS; Shirk P; Steele MK; Paul P; Paden CR; Cadwell B; Reese HE; Aoki Y; Hassell N; Zheng XY; Talarico S; Chen JC; Oberste MS; Batra D; McMullan LK; Halpin AL; Galloway SE; MacCannell DR; Kondor R; Barnes J; MacNeil A; Silk BJ; Dugan VG; Scobie HM; Wentworth DE; Caravas J; Kovacs NA; Gerhart JG; Jia Ng H; Beck A; Chau R; Cintron R; Cook PW; Gulvik CA; Howard D; Jang Y; Knipe K; Lacek KA; Moser KA; Paskey AC; Rambo-Martin BL; Nagilla RR; Retchless AC; Schmerer MW; Seby S; Shepard SS; Stanton RA; Stark TJ; Uehara A; Unoarumhi Y; Bentz ML; Burgin A; Burroughs M; Davis ML; Keller MW; Keong LM; Le SS; Lee JS; Madden Jr JC; Nobles S; Owuor DC; Padilla J; Sheth M; Wilson MM; ; MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(6):206-211. PubMed ID: 35143464 [TBL] [Abstract][Full Text] [Related]
15. Omicron Sub-Lineages (BA.1.1.529 + BA.*) Current Status in Ecuador. Carrazco-Montalvo A; Herrera-Yela A; Alarcón-Vallejo D; Gutiérrez-Pallo D; Armendáriz-Castillo I; Andrade-Molina D; Muñoz-Mawyin K; Fernández-Cadena JC; Morey-León G; Usfq-Covid-Consortium ; Crn Influenza Y Ovr-Inspi ; Patiño L Viruses; 2022 May; 14(6):. PubMed ID: 35746651 [TBL] [Abstract][Full Text] [Related]
16. First sequenced cases of Omicron BA.2 sublineage in Ecuador. Andrade-Molina DA; Morey-León GA; Muñoz-Mawyin KE; Cruz-Fatuly FF; Fernández-Cadena JC; Cárdenas P Virus Res; 2023 Sep; 334():199169. PubMed ID: 37406934 [TBL] [Abstract][Full Text] [Related]
17. Combining genomic data and infection estimates to characterize the complex dynamics of SARS-CoV-2 Omicron variants in the US. Lopes R; Pham K; Klaassen F; Chitwood MH; Hahn AM; Redmond S; Swartwood NA; Salomon JA; Menzies NA; Cohen T; Grubaugh ND Cell Rep; 2024 Jul; 43(7):114451. PubMed ID: 38970788 [TBL] [Abstract][Full Text] [Related]
18. Detection of a cluster of Omicron's BA.4 sublineage in Northern Senegal and identification of the first XAS recombinant variant in Senegal. Faye M; Faye MN; Ndiaye B; Diagne MM; Sankhe S; Top NM; Diallo A; Loucoubar C; Dia N; Sall AA; Faye O Virus Res; 2024 Jan; 339():199259. PubMed ID: 37926155 [TBL] [Abstract][Full Text] [Related]
19. Serum Neutralization of SARS-CoV-2 Omicron BA.1 and BA.2 after BNT162b2 Booster Vaccination. Pedersen RM; Bang LL; Madsen LW; Sydenham TV; Johansen IS; Jensen TG; Justesen US; Andersen TE Emerg Infect Dis; 2022 Jun; 28(6):1274-1275. PubMed ID: 35356875 [TBL] [Abstract][Full Text] [Related]
20. Receptor-Binding-Motif-Targeted Sanger Sequencing: a Quick and Cost-Effective Strategy for Molecular Surveillance of SARS-CoV-2 Variants. Chaki SP; Kahl-McDonagh MM; Neuman BW; Zuelke KA Microbiol Spectr; 2022 Jun; 10(3):e0066522. PubMed ID: 35638906 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]